These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 15312853

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W, FORI (Foramen Ovale Registro Italiano) Investigators.
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
    Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP, PICSS Investigators.
    Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.
    Pickett CA, Villines TC, Ferguson MA, Hulten EA.
    Tex Heart Inst J; 2014 Aug; 41(4):357-67. PubMed ID: 25120387
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P, Khalid MF, Khattak F, Bagai J, Bhogal S, Ladia V, Mukherjee D, Daggubati R, Paul TK.
    Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
    Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.
    Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population.
    Moon J, Kang WC, Kim S, Oh PC, Park YM, Chung WJ, Choi DY, Lee JY, Lee YB, Hwang HY, Ahn T.
    Yonsei Med J; 2016 May; 57(3):621-5. PubMed ID: 26996560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Five-year experience with percutaneous closure of patent foramen ovale.
    Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Liebeskind DS.
    Am J Cardiol; 2007 May 01; 99(9):1316-20. PubMed ID: 17478165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.